Glioblastoma Clinical Trials in Berlin
2 recruitingBerlin, Germany
Showing 1–2 of 2 trials
Recruiting
Phase 3
EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma
Glioblastoma
NovoCure GmbH741 enrolled82 locationsNCT06556563
Recruiting
Not Applicable
Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With Radiochemotherapy and Maintenance Chemotherapy in Patients With Glioblastoma (Brain-RF)
Glioblastoma
Charite University, Berlin, Germany26 enrolled1 locationNCT06140875